메뉴 바로가기 본문 바로가기
크게글자 크기작게프린트
Home  > 진료안내 > 진료과/의료진 > 의료진소개

의료진소개

심장내과

논문
1. Do U, Kim J, Kim M, Cho MS, Nam GB, Choi KJ, Kim YH. Esophageal Theraml Injury after Catheter Ablation for Atrial Fibrillation with High-Power (50 Watts) Radiofrequency Energy. Korean Circ J. 2021 Feb;51(2):143-153.
2. Cho MS, Choi KJ, Kim M, Do U, Kim J, Nam GB. Relation of Left Atrial Enlargement to Subsequent Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients With Low to Borderline Embolic Risk. Am J Cardiol. 2021 Jan 4:S0002-9149(20)31362-X.
3. Do U, Nam GB, Kim M, Cho MS, Kim J, Choi KJ, Kim YH. Inter/Intra-Atrial Dissociation in Patients With Maze Procedure and Its Clinical Implications: Pseudo-Block and Pseudo-Ventricular Tachycardia. J Am Heart Assoc. 2020 Dec;9(23):e018241.
4. Do U, Kim J, Kim M, Cho MS, Nam GB, Choi KJ, Kim YH. Association of pericardial effusion after pulmonary vein isolation and outcomes in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2020 Oct;43(10):1132-1138.
5. Do U, Ahn JM, Kang DY, Ko E, Kim HJ, Kim JB, Choo SJ, Park DW, Park SJ. Association and Prognostic Implication of C-Reactive Protein with Risk of 1-Year Death or Disabling Stroke After Transcatheter Aortic Valve Replacement. Structural Heart. 2019;3(4):312-320.
6. Yang TH, Jin HY, Choi KN, Do U, Kim HJ, Chung SR, Seo JS, Jang JS, Kim DK, Kim DS. Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI. Int J Cardiol. 2013 Sep 20;168(1):207-11.
저서